Hepatitis C Group Rejects Settlement Offer By Japanese Government, Drug Makers (Japan)
This article was originally published in PharmAsia News
Executive Summary
A group of people infected with hepatitis C after receiving contaminated blood has rejected a settlement agreement offered by drug makers and the Japanese government. The group is comprised of 13 patients out of an estimated 200 plaintiffs who contracted the disease after receiving the blood. The 13-member group said it rejected the offer because it would not properly compensate some of the 200. (Click here for more